Who
Cong Claire Xu
EVP, Clinical Development
Company insider
Files Form 4 as: EVP, Clinical Development, NovaBridge Biosciences.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $41K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 May 2026
- Last trade
- 31 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 1 Sep 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Sold | $2,5933,282 at $0.79 | filing |
| 31 Aug 2026filed 1 Sep 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Sold | $2,5933,282 at $0.79 | filing |
| 30 Aug 2026filed 1 Sep 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Code M | —9,382 | filing |
| 30 Aug 2026filed 1 Sep 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,079 at $0.00 | filing |
| 30 Aug 2026filed 1 Sep 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,079 at $0.00 | filing |
| 30 Aug 2026filed 1 Sep 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Code M | —9,382 | filing |
| 6 Jul 2026filed 7 Jul 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Sold | $3,9924,485 at $0.89 | filing |
| 6 Jul 2026filed 7 Jul 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Sold | $3,9924,485 at $0.89 | filing |
| 4 Jul 2026filed 7 Jul 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Code M | —12,432 | filing |
| 4 Jul 2026filed 7 Jul 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,405 at $0.00 | filing |
| 4 Jul 2026filed 7 Jul 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,405 at $0.00 | filing |
| 4 Jul 2026filed 7 Jul 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Code M | —12,432 | filing |
| 1 Jun 2026filed 2 Jun 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Sold | $14K3,494 at $3.94 | filing |
| 1 Jun 2026filed 2 Jun 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Sold | $14K3,494 at $3.94 | filing |
| 30 May 2026filed 2 Jun 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Code M | —9,382 | filing |
| 30 May 2026filed 2 Jun 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,079 at $0.00 | filing |
| 30 May 2026filed 2 Jun 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,079 at $0.00 | filing |
| 30 May 2026filed 2 Jun 2026 | NBP NovaBridge BiosciencesBiotechnology | SEC FORM 4 Code M | —9,382 | filing |
News
No headline names them, or the companies they trade most, lately.